We are live on
!
Find out more
GPCM
Granite Point Capital Management Portfolio holdings
AUM
$4.9M
1-Year Est. Return
38.41%
This Fund
S&P 500
This Quarter
Est. Return
+7.87%
1 Year Est. Return
+38.41%
3 Year Est. Return
+124.67%
5 Year Est. Return
+295.96%
10 Year Est. Return
–
AUM
$145M
AUM Growth
+$5.55M
(+4%)
Cap. Flow
-$682K
Cap. Flow
% of AUM
-0.47%
Top 10 Holdings %
Top 10 Hldgs %
56.79%
Holding
122
New
20
Increased
8
Reduced
57
Closed
34
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$45.4M |
| 2 |
VSA
VisionSys AI
VSA
|
+$3.41M |
| 3 |
Vipshop
VIPS
|
+$2.21M |
| 4 |
Methode Electronics
MEI
|
+$1.53M |
| 5 |
CBPO
China Biologic Products Holdings, Inc.
CBPO
|
+$1.43M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MONT
MONTAGE TECHNOLOGY GROUP LTD
MONT
|
+$3M |
| 2 |
HIMX
Himax Technologies
HIMX
|
+$2.3M |
| 3 |
Meta Platforms (Facebook)
META
|
+$1.97M |
| 4 |
GOMO
SUNGY MOBILE LTD ADS
GOMO
|
+$1.7M |
| 5 |
CSII
Cardiovascular Systems, Inc.
CSII
|
+$1.67M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.01% |
| 2 | Consumer Discretionary | 9.89% |
| 3 | Consumer Staples | 6.5% |
| 4 | Technology | 6.3% |
| 5 | Communication Services | 5.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Neurocrine Biosciences
NBIX
$16.8B
| $668K | 0.46% |
45,000
-19,800
| -31% | -$279K |
|
52
VanEck Gold Miners ETF
GDX
$22.7B
| $661K | 0.45% |
25,000
-11,000
| -31% | -$264K |
|
|
NPSP
53
DELISTED
NPS PHARMACEUTICALS INC
NPSP
| $661K | 0.45% |
20,000
-21,000
| -51% | -$607K |
|
54
LeMaitre Vascular
LMAT
$2.32B
| $628K | 0.43% |
75,900
-10,205
| -12% | -$79.8K |
|
|
FPRX
55
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $622K | 0.43% |
40,000
-17,600
| -31% | -$252K |
|
56
Eterna Therapeutics
ERNA
$3.83M
| $588K | 0.4% |
1
| – | – |
|
57
Steris
STE
$22.3B
| $535K | 0.37% |
10,000
-5,000
| -33% | -$258K |
|
58
TherapeuticsMD
TXMD
$23.5M
| $530K | 0.36% |
2,400
+180
| +8% | +$40.1K |
|
|
SOHU
59
Sohu.com
SOHU
$362M
| $519K | 0.36% |
9,000
-14,800
| -62% | -$863K |
|
|
XLRN
60
DELISTED
Acceleron Pharma
XLRN
| $510K | 0.35% |
15,000
-13,800
| -48% | -$461K |
|
61
OneSpan
OSPN
$574M
| $499K | 0.34% |
+43,000
| New | +$447K |
|
62
MiMedx Group
MDXG
$602M
| $496K | 0.34% |
70,000
-23,000
| -25% | -$135K |
|
|
ACTS
63
DELISTED
Actions Semiconductor Co
ACTS
| $476K | 0.33% |
200,000
-100,000
| -33% | -$216K |
|
|
WMGI
64
DELISTED
Wright Medical Group Inc
WMGI
| $471K | 0.32% |
15,000
-4,500
| -23% | -$134K |
|
|
NORD
65
DELISTED
Nord Anglia Education, Inc.
NORD
| $458K | 0.32% |
+25,000
| New | +$462K |
|
|
CORE
66
DELISTED
Core Mark Holding Co., Inc.
CORE
| $456K | 0.31% |
+20,000
| New | +$409K |
|
|
ALXN
67
DELISTED
Alexion Pharmaceuticals
ALXN
| $422K | 0.29% |
2,700
-1,000
| -27% | -$158K |
|
68
STAAR Surgical
STAA
$1.21B
| $420K | 0.29% |
25,000
-11,000
| -31% | -$181K |
|
|
SAUC
69
DELISTED
Diversified Restaurant Holdings, Inc. Common stock
SAUC
| $420K | 0.29% |
+88,000
| New | +$409K |
|
|
DMK
70
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
| $403K | 0.28% |
1,196
-133
| -10% | -$52.2K |
|
|
AIFU
71
AIFU Inc
AIFU
$206M
| $400K | 0.28% |
146
-16
| -10% | -$44.3K |
|
|
KZ
72
DELISTED
KongZhong Corporation
KZ
| $394K | 0.27% |
45,360
-5,040
| -10% | -$48.9K |
|
|
DENN
73
DELISTED
Denny's
DENN
| $359K | 0.25% |
55,000
-24,200
| -31% | -$158K |
|
74
uniQure
QURE
$3.03B
| $340K | 0.23% |
25,000
-15,000
| -38% | -$163K |
|
75
Talphera
TLPH
$66.4M
| $308K | 0.21% |
1,500
-1,560
| -51% | -$313K |
|
Similar funds
MAM
CCM
BGCI
CAM
EAM
SM
TPL
RC
Granite Point Capital Management's Q2 2014 Portfolio in Review
As of Q2 2014, Granite Point Capital Management held 122 positions worth $145M, up 4% from $140M the previous quarter. Its ten largest holdings account for 57% of the portfolio.
Granite Point Capital Management's Q2 2014 filing shows 20 new, 8 increased, 57 reduced and 34 closed positions. Its largest new stake was iShares Russell 2000 ETF: 400,000 shares worth $47.5M. The largest sale was MONTAGE TECHNOLOGY GROUP LTD, an estimated $3M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 28% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.
- Granite Point Capital Management's largest Q2 2014 buy was iShares Russell 2000 ETF: 400,000 shares worth $47.5M.
- Granite Point Capital Management added most to Vipshop in Q2 2014, an estimated $2.21M increase.
- Granite Point Capital Management's biggest Q2 2014 reduction was Meta Platforms (Facebook), cutting an estimated $1.97M.
- Granite Point Capital Management fully exited MONTAGE TECHNOLOGY GROUP LTD in Q2 2014, selling an estimated $3M.
- Granite Point Capital Management's ten largest holdings make up 57% of its $145M portfolio in Q2 2014.
- Granite Point Capital Management opened 20 new positions and closed 34 in Q2 2014.
- Granite Point Capital Management's portfolio value rose 4% quarter-over-quarter to $145M.
Based on Granite Point Capital Management's 13F filing for Q2 2014, filed 13 Aug 2014.